Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-131-CLR1404 in Recurrent Glioma
NCT01778088Phase 2Withdrawn
- Sponsor
- Cellectar Biosciences
- Start
- May 2014
- Primary completion
- Jun 2014
- Countries
- 1
01
Overview
A Phase 2 trial of Iopofosine I-131 in glioma, sponsored by Cellectar Biosciences. Planned start May 2014; status: withdrawn.
02
Drugs
Iopofosine I-131
03
Conditions
glioma
Beyond the preview
Go deeper on NCT01778088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01778088.